New α-galactosidase-inhibiting aminohydroxycyclopentanes

Area of Science:

• Carbohydrate Chemistry
• Medicinal Chemistry
• Enzymology

Background:

• Alpha-galactosidase is a key enzyme involved in various biological processes.
• Developing specific inhibitors for alpha-galactosidase is crucial for understanding its function and for therapeutic applications.
• Cyclopentanoid structures offer a promising scaffold for enzyme inhibition.

Purpose of the Study:

• To synthesize a novel series of cyclopentanoid ligands.
• To evaluate the potential of these compounds as alpha-galactosidase inhibitors.
• To explore structure-activity relationships for glycosidase inhibition.

Main Methods:

• Preparation of cyclopentanoid ligands from a partially protected ω-eno-aldose using a (2 + 3)-cycloaddition protocol.
• Selective opening of the N-benzylisoxazolidine ring and inversion of the hydroxymethyl group configuration.
• Deprotection and N-alkylation to yield the final aminocyclopentane derivatives.
• Screening of glycosidase inhibitory activities against a panel of standard glycosidases.

Main Results:

• Successful synthesis of a diverse set of cyclopentanoid compounds.
• Identification of potential alpha-galactosidase inhibitors within the synthesized library.
• Demonstration of the utility of the cycloaddition strategy for generating complex carbohydrate mimetics.
• Initial screening data provides insights into the inhibitory potential against various glycosidases.

Conclusions:

• The developed synthetic route is effective for preparing cyclopentanoid alpha-galactosidase ligands.
• The synthesized compounds show promise as inhibitors of alpha-galactosidase and potentially other glycosidases.
• Further investigation is warranted to optimize these ligands for therapeutic development.